On this page
What the Market Watch is and who it is for
Each edition goes through the official records of the previous month. Which medicines the EMA authorised and which the FDA approved, how many industry trials with biologics started in Europe, the United States, Asia and Latin America, and how EU imports of equipment under heading 8419.89 are moving.
It is written for the people who run marketing or sales at a European supplier of bioprocess equipment or services. These are counts from public sources with the method in plain sight, not a demand forecast.
How often does Bioprocess Market Watch come out?
Every month. Each edition gathers the public data for the previous month and comes out once the sources have published it.
All editions
The first in the list is the newest edition. Each one carries the key figure of the month, the charts, the method and the data as CSV and JSON.
- October 2026. 10 industry biologics trials started in Europe in September 2026
- September 2026. 6 industry biologics trials started in Europe in August 2026
- August 2026. 7 industry biologics trials started in Europe in July 2026
- July 2026. 10 industry biologics trials started in Europe in June 2026
- June 2026. 10 industry biologics trials started in Europe in May 2026
- May 2026. 11 industry biologics trials started in Europe in April 2026
- April 2026. 8 industry biologics trials started in Europe in March 2026
- March 2026. 13 industry biologics trials started in Europe in February 2026
- February 2026. 6 industry biologics trials started in Europe in January 2026
- January 2026. 17 industry biologics trials started in Europe in December 2025
Reviewing next quarter's sales plan with these figures and want a second opinion? Tell us where you are and we can talk it through, with no commitment.
Tell us about itWhere the data comes from
Every figure comes from public sources, queried the same way each month. Each edition gives the exact query, the download date and the limits of each source.
- EMA, the table of medicines authorised in the EU
- FDA, CDER novel drug approvals and CBER biologics licence approvals
- FDA, warning letters for good manufacturing practice
- ClinicalTrials.gov, industry trials with biologics
- Eurostat, EU imports under heading 8419.89
- ANVISA and PMDA, registrations in Brazil and Japan
Are the Market Watch counts demand for bioprocess equipment?
No. They are official records, such as trials that start or medicines that get authorised, and import values from Eurostat. They show where there is activity, but not how much equipment or how many consumables will be bought, or by whom.
How to use the data
The data and the charts are under a CC BY 4.0 licence. You can use them in presentations, reports or articles if you credit crida studio and link to this page or to the edition they come from.
A new edition comes out every month, once the sources have published the data for the previous month. This address does not change and the list is always up to date.
Can I use the Market Watch data?
Yes. The data and the charts are under a CC BY 4.0 licence. Credit crida studio and link to this page or to the edition the figures come from.